Corneal endothelial permeability in protection glaucoma filter bleb with tissue plasminogen activator.
After glaucoma filtering surgery subconjunctival injection of human recombinant tissue plasminogen activator may promote the function of glaucoma filter bleb and increase outflow facility. It can also increase postoperative complications, such as corneal damage. The aim of our research was to determine corneal endothelial permeability (Pac) in subjects with glaucoma filter bleb protected by a plasminogen activator (Actilyse, Boehringer) when haemorrhagic clots obstructing a glaucoma filtering site had occurred. Two weeks, three months and six months after goniotrephining with scleral cover, in groups with and without subconjunctival injection of 25 mg human tissue plasminogen activator, Pac was calculated. In both groups, no significant differences in the level of Pac measured by fluorophotometry were found.
Szymanski
A
A
Department of Ophthalmology, Silesian Academy of Medicine, Katowice, Poland.
Gierek-Lapinska
A
A
Koziak
M
M
Gierek-Kalicka
S
S
D000368:Aged; D017024:Chemotherapy, Adjuvant; D004728:Endothelium, Corneal / Q000166:cytology / Q000378:metabolism*; D005260:Female; D018463:Filtering Surgery; D019793:Fluorescein; D005452:Fluoresceins / Q000378:metabolism; D015590:Fluorophotometry; D005902:Glaucoma, Open-Angle / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D010539:Permeability; D010960:Plasminogen Activators / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects
D005452:Fluoresceins; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D019793:Fluorescein